Blogs
Oral antiplatelet therapy – half a century of evolution
It is now 50 years since the first randomised, controlled trial of aspirin in the secondary prevention of mortality from myocardial infarction (MI)[1]. Although the
Celebrating our fifth anniversary
Recently we celebrated five years as Platelet Services and in this blog we are looking back on some of our highlights over the last five
American College of Toxicology (ACT) 44th Annual Meeting: post event round-up
Platelet Services’ Natalia Dovlatova and Charlotte Jewell recently spent several days in Orlando, Florida while attending the American College of Toxicology (ACT) 44th Annual Meeting
Therapeutic antibodies can have an effect on platelet function
Monoclonal antibodies (mAbs) are being discovered and developed as new therapeutic approaches to combat different diseases such as cancers, autoimmune diseases, HIV and more. Some
Meet the team: Dr Paul Cato
Senior Research Scientist, Paul Cato, started out his career in haematology and shares the career journey that led him back to working with platelets here
Andrew Johnson: Celebrating 40 years in science
Andrew Johnson is the Laboratory Manager at Platelet Services and this year, he celebrates 40 years working in science. In our latest blog, Andrew shares
